Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4018 studies found for:    Open Studies | "Immune System Diseases"
Show Display Options
Rank Status Study
21 Recruiting Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
22 Recruiting Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD
Condition: Graft vs Host Disease
Interventions: Biological: Begelomab;   Biological: Conventional Second-line Treatment
23 Recruiting Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: Entospletinib;   Drug: Placebo;   Drug: Systemic Corticosteroids
24 Not yet recruiting Women Empowered to Live With Lupus Study
Condition: Lupus Erythematosus, Systemic
Intervention: Behavioral: Chronic Disease Self-Management Program (CDSMP)
25 Recruiting A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: KD025
26 Recruiting Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
Conditions: Lymphoma;   Lymphoma, Non-Hodgkin;   Immune System Diseases;   Immunoproliferative Disorders;   Lymphatic Diseases;   Lymphoproliferative Disorders;   Neoplasms;   Neoplasms by Histologic Type
Intervention: Biological: ATLCAR.CD30 cells
27 Recruiting Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
Conditions: Hodgkin Disease;   Lymphoma;   Lymphoma, Non-Hodgkin;   Immune System Diseases;   Immunoproliferative Disorders;   Lymphatic Diseases;   Lymphoproliferative Disorders;   Neoplasms;   Neoplasms by Histologic Type
Intervention: Drug: ATLCAR.CD30 cells
28 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections;   Unknown Immune Deficiency;   GATA2 Deficiency (MonoMAC);   Nontuberculous Mycobacterial Infections;   Hyper IgE (Job s) Syndrome;   Leukocyte Adhesion Deficiency;   Susceptibility to Disseminated Infections;   Primary Immune Deficiency Disease (PIDD)
Intervention:
29 Recruiting A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Conditions: Eczema;   Dermatitis;   Dermatitis, Atopic;   Genetic Disease, Inborn;   Hypersensitivity;   Hypersensitivity, Immediate;   Immune System Diseases;   Skin Diseases;   Skin Diseases, Eczematous;   Skin Diseases, Genetic
Interventions: Other: Care provided by general pediatrician;   Other: Care provided by pediatric dermatologist
30 Not yet recruiting A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders
Conditions: MDS;   Systemic Autoimmune Diseases
Intervention: Drug: Azacitidine
31 Recruiting Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)
Conditions: Dry Eye;   Ocular Graft vs Host Disease;   Meibomian Gland Dysfunction
Interventions: Drug: Brimonidine 0.15%;   Drug: Brimonidine 0.075%;   Drug: Placebo
32 Recruiting Testicular Tissue Cryopreservation for Fertility Preservation
Conditions: Cancer;   Autoimmune Disorders
Intervention: Procedure: Testicular biopsy
33 Not yet recruiting Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide
Condition: Chronic Graft-Versus-Host Disease
Intervention: Drug: Arsenic Trioxide Injectable Solution
34 Recruiting Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD)
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: ibrutinib;   Drug: Placebo;   Drug: Prednisone
35 Not yet recruiting A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD
Condition: Graft Versus Host Disease
Interventions: Biological: GLASSIA;   Drug: methylprednisolone or equivalent steroid;   Biological: Albumin
36 Recruiting Evaluation of the Efficacy of the Sequencing Method by Gene-panel
Condition: Primary Immuno-Deficiencies
Intervention: Biological: Blood sampling
37 Recruiting A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Condition: Graft-versus-host Disease
Interventions: Drug: Ruxolitinib;   Drug: Prednisone or methylprednisolone
38 Not yet recruiting Clinical Evaluation for Post Bleaching Hypersensitivity Using Desensitizing Agent During In-office Bleaching
Condition: Tooth Bleaching
Interventions: Other: ACP oral care gel;   Other: glycrin
39 Recruiting Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study
Condition: Non Celiac Gluten Sensitivity
Interventions: Dietary Supplement: High dose Gluten;   Dietary Supplement: Low dose Gluten;   Dietary Supplement: Lactose free placebo
40 Not yet recruiting Day and Night Closed-loop in Young People With Type 1 Diabetes
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Glucose Metabolism Disorders;   Endocrine System Diseases;   Autoimmune Diseases
Interventions: Device: FlorenceM;   Device: Insulin pump therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.